CLINICAL TESTS OF DIGESTION AND ABSORPTION
A large number of tests of varying degrees of complexity and specificity are potentially useful in the study of patients suspected of having abnormalities of digestion and/or absorption. Some of the most useful of these tests will be described briefly.
Fecal Fat Analysis. As a screening measure a qualitative test for stool fat using a Sudan III stained smear is useful in the detection of steatorrhea. The standard, however, is to measure quantitatively the amount of fat in a three-day stool specimen after the patient has ingested a diet containing 80 to 100 grams of fat daily. Normal fat excretion in these circumstances is less than 6 grams per 24 hours (usually 2.5 grams). Values higher than this reliably indicate fat malabsorption (steatorrhea) but do not indicate the pathogenesis of the abnormality.
Triolein Breath Test. This test using 14C-tri-olein reflects the rate of absorption of this radioactive triglyceride rather than the amount not absorbed, but otherwise its use is comparable to that of quantitative fecal fat analysis. Expired 14C02 is measured hourly for six hours, and normally more than 3.5 per cent of the radioactivity administered as the triolein is recovered under these conditions.
Xy lose Absorption-excretion Test. The absorption of D-xylose, a poorly metabolized 5-carbon sugar, reflects the integrity of carbohydrate absorption by the proximal small intestine. Since no enzymatic digestion or solubilization is required prior to absorption, the rate of absorption is unaffected by pancreatic or hepatic (biliary) disease and is a more selective test of mucosal integrity. Usually 25 grams of D-xylose are given orally to a well-hydrated subject, and the amount of the sugar excreted in the subsequent five-hour urine is measured. Normal values exceed 4.5 grams per 5 hours, but this figure may be reduced by age, decreased renal function, excessive body fluid (ascites, edema), or intestinal bacterial overgrowth. In the latter case the test should return to normal with the use of antibiotics. As a variation the plasma xylose can be measured one hour after xylose is ingested and should exceed 30 mg/dl.
Radiographic Studies. All patients with malabsorption should have radiographic studies of the stomach and small intestine. Often the findings are nonspecific, with thickening of the mucosal folds, modest dilatation of the intestinal lumen, and clumping and segmentation of the barium in a so-called moulage pattern. Occasionally the study may be diagnostic with the demonstration of a stricture, a fistula, or a “blind-loop” (e.g., a small bowel diverticulum). The findings may guide the use of other studies such as biopsy.
Smallintestinal (Jejunal) Biopsy. Peroral biopsy of the small intestinal mucosa is frequently indicated in the investigation of malabsorption. summarizes the conditions in which the biopsy is likely to be diagnostic and those in which it is often abnormal but in a nonspecific way.
Vitamin Bu Absorption (the Schilling Test). Vitamin BJ2 (cobalamin) is selectively absorbed in association with intrinsic factor in the distal ileum. An abnormality in its absorption usually represents one or more of four abnormalities:
(a)disease of the distal ileum (e.g., Crohn’s disease), (b] deficiency of intrinsic factor, (c) deficient pancreatic exocrine function (pancreatic trypsin is necessary to release cobalamin from a binding “R-protein” of gastric juice so that it is free to combine with intrinsic factor), and (d) increased utilization of cobalamin during transit (e.g., bacterial overgrowth). In the usual form of the test, radioactive vitamin B12 is given orally either alone, with intrinsic factor, or after therapy with a broad-spectrum antibiotic in suspected bacterial overgrowth, and its urinary excretion is measured over 24 hours. A flushing dose of 1.0 mg vitamin B12 is given simultaneously to prevent its hepatic storage and to enhance excretion. Normally more than 7 per cent of the orally administered radioactive vitamin B12 will be recovered in the urine. The pattern of abnormalities found in the sequential Schilling test may suggest (a) all three stages abnormal—intrinsic intestinal disease or pancreatic exocrine insufficiency; (b) stage 1 abnormal, stage 2 normal—intrinsic factor deficiency (pernicious anemia); (c) stages 1 and 2 abnormal, stage 3 normal—bacterial overgrowth.
Other Breath Tests. Several breath tests that assess abnormal rates of intraluminal bacterial metabolism of specific compounds have been developed. In the bile acid breath test, a 14C-glycine conjugate of a bile acid is given orally and the rate of expired 14C02 is measured. Normally most bile salts are recycled intact in an enterohepatic circulation involving ileal reabsorption. Rapid metabolism of the conjugated glycine to C02 reflects either bacterial overgrowth within the small intestine or a blind loop from it, while a delayed but increased production of 14C02 indicates ileal dysfunction with increased spillage of the bile salt into the colon. In an analogous fashion, intraluminal bacterial metabolism of sugars releases free hydrogen, which can be measured in expired air. Most frequently this test is used to assess specific disorders of carbohydrate digestion and absorption, such as lactase deficiency, in which expired H2 is measured after the ingestion of 50 grams of lactose.
Miscellaneous Tests. There are many other important although nonspecific tests that may reflect malabsorption, such as body weight, serum albumin, the prothrombin time (absorption of the fatsoluble vitamin K), and serum levels of cholesterol, carotene, folic acid, calcium, and magnesium. All of these tests measure only the results of malabsorption and are, in general, of little help in its differential diagnosis.
- Proliferative Glomerulonephritis
- MOTOR DISORDERS OF THE ESOPHAGUS
- CLINICAL AMD LABORATORY FEATURES
- C. MALABSORPTION
- Vitamin Dresistant Rickets
- RHEUMATIC FEVER
- CARDIOVASCULAR RESPONSE TO EXERCISE
- SYNCOPE
- Visceral Angiography
- SCREENING TESTS OF HEPATOBILIARY DISEASE
- Procainamide
- CLASSIFICATION OF THE MALABSORPTION SYNDROMES
- CLINICAL SYMPTOMS OF ESOPHAGEAL DISEASE
- DRUGS
- CLINICAL FEATURES OF PULMONARY HYPERTENSION
- Liddle’s Syndrome
- CHRONIC RENAL FAILURE
- Metabolism of Drugs in Patients with Renal Insufficiency
- PROSTHETIC VALVES
- PERICARDIAL EFFUSIOH
- Gastrointestinal Tract
- CLINICAL APPROACH TO LIVER DISEASE
- THROMBOANGIITIS OBLITERANS
- VARIATiT ANGINA
- MEDICAL MANAGEMENT OF ANGINA
- MICROSCOPIC ANATOMY
- MYOCARDIAL METABOLISM
- APPROACH TO THE DIAGNOSIS OF JAUNDICE
- OXYGEN THERAPY AND MECHANICAL VENTILATION
- Reduction in GFR
- Hepatocellular Carcinoma
- NONOBSTRUCTIVE CAUSES OF ISCHEMIC HEART DISEASE
- Aspiration Pneumonia and Lung Abscess
- Hepatic Diseases
- RENAL PARENCHYMAL